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Abstract
Introduction: Postoperative delirium and pain are common complications in
adults, and are difficult both to prevent and treat. Obstructive sleep apnea
(OSA) is prevalent in surgical patients, and has been suggested to be a risk
factor for postoperative delirium and pain. OSA also might impact pain
perception, and alter pain medication requirements. This protocol describes an
observational study, with the primary aim of testing whether OSA is an
independent predictor of postoperative complications, focusing on (i)
postoperative incident delirium and (ii) acute postoperative pain severity. We
secondarily hypothesize that compliance with prescribed treatment for OSA
(typically continuous positive airway pressure or CPAP) might decrease the risk
of delirium and the severity of pain.
Methods and analysis: We will include data from patients who have been
enrolled into three prospective studies: ENGAGES, PODCAST, and
SATISFY-SOS. All participants underwent general anesthesia for a
non-neurosurgical inpatient operation, and had a postoperative hospital stay of
at least one day at Barnes Jewish Hospital in St. Louis, Missouri, from February
2013 to May 2018. Patients included in this study have been assessed for
postoperative delirium and pain severity as part of the parent studies. In the
current study, determination of delirium diagnosis will be based on the
Confusion Assessment Method, and the Visual Analogue Pain Scale will be
used for pain severity. Data on OSA diagnosis, OSA risk and compliance with
treatment will be obtained from the preoperative assessment record. Other
variables that are candidate risk factors for delirium and pain will also be
extracted from this record. We will use logistic regression to test whether OSA
independently predicts postoperative delirium and linear regression to assess
OSAs relationship to acute pain severity. We will conduct secondary analyses
with subgroups to explore whether these relationships are modified by
compliance with OSA treatment.
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REVISED

Amendments from Version 1

This revised protocol addresses the referees’ questions and
suggestions. Specifically, we provided more information
regarding the parent studies of this project. Patient selection is
described in greater detail, and we updated our figures with new
cohort estimates. We also improved our statistical models with
suggestions from our reviewers. Our models now incorporate
adjustments for certain intraoperative medications as well as
additional comorbidities. Compared to existing literature, one of
the greatest strengths of this study is the rigorous data collection
on a broad surgical population. We believe these pre-analytical
modifications to our models will create a more robust analysis that
promotes research integrity and reproducibility.
See referee reports

Introduction
Obstructive sleep apnea (OSA) is the most common form of
sleep-disordered breathing. OSA is characterized by repetitive,
functional collapse of the airway leading to cyclical decrements
or cessations of airflow during sleep1. It is estimated that 20% of
the general population suffers from OSA2,3, and among adults with
OSA, up to 75% are unaware of the diagnosis4,5. Of relevance to
perioperative medicine, there is also a high OSA prevalence in
surgical patients3. In common with the general population, many
of these patients are unaware they have OSA6,7. Also of note,
prevalence of sleep apnea often varies by type of surgery; for
example, prevalence in the bariatric surgery population is
estimated to be 70%8,9. OSA prevalence combined with ignorance
of diagnosis is cause for concern given the wide range of health
consequences. OSA has been causally implicated in an assortment
of both acute and chronic disorders. Acutely, OSA has been
associated with disrupted sleep, tiredness, and episodic hypoxia
and hypercapnia during sleep10,11. Chronically, OSA has been
linked to a multitude of co-morbidities, including ischemic heart
disease and stroke12, hypertension13,14, arrhythmias15,16, aortic
dissection17,18, chronic fatigue19, pulmonary hypertension20,21,
diabetes22, and respiratory acidosis with compensatory metabolic
alkalosis23,24.
OSA is becoming a growing concern in the perioperative period,
as there is increasing evidence linking OSA to adverse
postoperative outcomes25,26. For example, following various
surgical procedures, patients with OSA probably have more
respiratory, cardiac, and neurologic complications27–30, as well
as increased postoperative infections31. Unsurprisingly surgical
patients with OSA therefore have a higher transfer rate to the
ICU28, increased stay in the ICU31, and increased overall length of
hospital stay27,28.
Of particular relevance to the research focus of this protocol,
certain aspects of OSA such as recurrent hypoxemia, systemic
inflammation, and sleep disruption have been associated with
altered pain processing and incident delirium32–34. A causal link
between OSA and delirium would be clinically important given
the negative outcomes associated with postoperative delirium.
In the DSM-5, delirium is defined as a disturbance in attention,
awareness, and cognition that develops over a short period of time
and over the course of a day, fluctuates in severity35. In older adults,

the incidence of postoperative delirium ranges from 10–70%,
depending on the type of surgery36. Patients who experience
postoperative delirium often require an extended stay in the intensive care unit37, subsequently report decreased quality of life38,
and might be at increased risk for accidental falls, long-term
cognitive decline and death after hospital discharge39. Thus,
postoperative delirium is associated with a considerable burden
on patients and their families, and an increase to society in the
overall cost of healthcare40,41.
The reported impact of OSA on postoperative pain and pain
perception poses further challenges to clinicians and patients.
Adequate postoperative analgesia is an important component of
recovery, and pain negatively impacts quality of life. Mechanistic
evidence in various populations suggests that sleep deprivation
promotes up-regulation of cytokines42–47, including interleukin-1β,
interleukin-6, and tumor necrosis factor, all of which might induce
excessive sensitivity to pain45,48. Consistent with these studies
clinical evidence, including compelling data from burn victims, suggests that interrupted and inadequate sleep promotes
hyperalgesia32–34,49. Furthermore, Khalid et al. showed that
treatment with continuous positive airway pressure (CPAP) in
adults with OSA dampened their sensitivity to painful stimuli50.
Thus, whether or not people with OSA have increased pain sensitivity might to some extent depend on how effectively they are
treated. To complicate matters further, people with OSA, especially
if they experience episodic hypoxemia during sleep, reportedly
have increased susceptibility to the respiratory depressant effects
of opioid medications51,52. Thus, since opioids are the mainstay of
therapy for severe postoperative pain, it can be especially difficult
to provide safe and adequate analgesia to surgical patients with
OSA.
The objectives of this study are to investigate further the
relationships between OSA on the one hand, and common
postoperative complications such as pain and delirium on the
other hand. We hypothesize that patients with OSA experience
more severe postoperative pain and have a higher incidence of
postoperative delirium. We further hypothesize these negative
outcomes might be mitigated by compliance with OSA treatment.

Protocol
Study design
This protocol describes a retrospective study, investigating the
relationship between OSA as a risk factor, and postoperative
delirium and acute postsurgical pain severity as adverse outcomes.
The three parent studies from which the data are being obtained
for the current study have all been approved by the Human
Research Protection Office (HRPO) at Washington University, and
patients enrolled in all three studies provided written informed
consent. The HRPO has also provided approval for this current
study. Data will be aggregated from the Systematic Assessment
and Targeted Improvement of Services Following Yearlong
Surgical Outcomes Surveys Study (SATISFY-SOS, NCT02032030);
the Electroencephalography Guidance of Anesthesia to Alleviate
Geriatric Syndromes study (ENGAGES, NCT02241655); and
the Prevention of Delirium and Complications Associated with
Surgical Treatments study (PODCAST, NCT01690988).
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The PODCAST trial investigated if a single subanesthetic dose of
ketamine could decrease postoperative incident delirium. There
was no significant difference in delirium incidence across the
three treatment groups (placebo, 0.5 mg/kg subanesthetic dose of
ketamine, 1.0 mg/kg subanesthetic does of ketamine). Additionally,
there was no apparent difference in reported pain between the
three groups. However, to be conservative, we will adjust for
PODCAST group allocation in the regression models in the
current study. To control for potential effects of the ENGAGES
intervention (Electroencephalography guided anesthesia vs.
non-electroencephalography guided anesthesia), we will adjust
our regression model for this randomization. For greater detail
regarding the three parent studies, please review previously
published protocols and literature53–57.
We will include an estimated 1,500 patients in our primary
analysis. Of the 672 patients randomized for the multicenter
PODCAST trial, we will include only patients recruited from
Washington University in St. Louis. The study population will
be comprised of roughly 100 patients from PODCAST and an
estimated 1,200 patients from the ENGAGES trial. SATISFYSOS is a large scale outcomes survey study, and we will be using
a subset of roughly 200 patients enrolled in SATISFY-SOS who
completed daily delirium and pain assessments during hospital
stay.
Patients ≥ 18 years who underwent general anesthesia for a
non-neurosurgical inpatient operation at Barnes Jewish Hospital
in St. Louis, Missouri, from February 2013 to May 2018, will be
included in our analysis. Patients had a postoperative hospital stay
of at least one day. The main outcomes of interest will include
postoperative delirium and pain, assessed daily until postoperative
day 3. The primary aims of this study are to investigate whether
OSA is an independent predictor of postoperative delirium and
acute postsurgical pain severity. We will conduct secondary
analyses with subgroups to explore whether these associations
are modified by compliance with OSA treatment. We are also
interested in evaluating if OSA status is related to postoperative
opioids given during hospital stay. Thus, we will secondarily
explore the relationship between OSA risk and total inpatient
opioid use through postoperative day 3.
This protocol is compliant with published guidelines for observational study protocols, and the conduct and reporting of this
study will adhere to the RECORD and STROBE guidelines
for observational studies58–60.

Eligibility criteria
Inclusion criteria:
(i) Enrollment in the SATISFY-SOS, ENGAGES, or PODCAST
study;
(ii) Postoperative stay of at least 1 day following surgery at Barnes
Jewish Hospital
(iii) General anesthesia for elective surgical procedures
Exclusion criteria:
(i) Neurosurgery
(ii) Age <18

Data collection
i. Baseline Data. Patients undergoing elective surgery are
routinely screened at the Center for Preoperative Assessment
and Planning at Barnes Jewish Hospital in St. Louis, Missouri,
where detailed medical history is collected and screening
tests are administered, including the STOP-BANG (Snoring,
Tiredness, Observed Apnea, High Blood Pressure, Body Mass
Index>35kg/m2, Age >50, Neck circumference, male Gender) test
for OSA risk. Baseline characteristics will be extracted via electronic chart review and will include but are not limited to: age, sex,
race, ethnicity, smoking history, alcohol use (average per week),
STOP-BANG criteria, OSA status, and pre-existing medical
conditions.
ii. Delirium assessment method. Delirium is one of the primary
outcomes of this study and will be determined using validated
delirium assessments implemented by a small group of rigorously
trained research assistants. Delirium for the parent studies was
assessed predominantly using the Confusion Assessment Method
(CAM)61,62. If patients were unwilling to complete the full CAM,
the 3D-CAM was used. The 3D-CAM was developed as a
method to more efficiently screen patients for delirium. It consists
of a subset of the questions used in the CAM, as well as CAM
scoring items that are based on patient behavior (10 cognitive
testing items, 10 interviewer observations). With this approach,
the 3D-CAM is intended to only take 3 minutes. For critically
ill patients, most often found in the intensive care unit, the
CAM-ICU was used to assess delirium63.
In the PODCAST trial, Delirium was assessed twice daily
(morning and afternoon with at least 6 hours between assessments), while in the other trials, delirium was assessed once daily
between 1pm and 8pm. We will include only the afternoon delirium assessments from PODCAST patients so all patients included
in analysis were assessed during the same time frame. Although
patients were assessed for delirium on postoperative day zero at
least 2 hours after surgery, we will not include this assessment
because of potential residual general anesthetic effects. We will
adjust for the use of certain medications, such as preoperative
midazolam, median volatile anesthetic concentration (converted to
minimum alveolar concentration [MAC] equivalents), intraoperative ketamine, and intraoperative opioids (converted to morphine
equivalents in mg).
The presence of delirium will be defined as a positive CAM
during any postoperative assessment through postoperative day 3.
In order to qualify for a diagnosis of delirium, the following
three criteria must be met: 1) either acute onset OR a fluctuating
course; 2) inattention; and 3) either disorganized thinking OR
altered level of consciousness. A patient will be considered
positive for delirium if the patient is recorded to have had
a single instance of delirium during their postoperative stay.
iii. Pain Assessment Method. Pain during hospital stay will be
assessed using the Visual Analogue Scale (VAS), a validated
pain assessment instrument that has been widely used in adult
populations64,65. Patients are asked to indicate on a line 100mm in
length the severity of their pain in three different situations: 1) at
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rest, 2) taking a deep breath or coughing, and 3) moving (sitting
up, walking, or moving extremities). The patient’s mark is then
measured with a ruler and recorded in mm. For our analysis, we
will incorporate the highest pain score recorded on any
postoperative assessment as our value of interest. As postsurgical
pain is often dependent on the type of surgery, we will adjust
for type of surgery in our statistical model, as well as other
confounding variables described in the methods below.
iv. OSA Classification. For the primary analysis (Figure 1),
patients will be grouped into one of three categories: high risk of
OSA (HR-OSA), intermediate risk of OSA (IR-OSA), and low
risk of OSA (LR-OSA). Patients with a history of a positive polysomnography test will be classified as HR-OSA, whereas patients
with a history of negative polysomnography will be classified as
LR- OSA. Patients with no history of polysomnography testing
will be classified into one of the three categories based on
STOP-BANG screening status. The STOP-Bang questionnaire classifies patients into three commonly accepted categories
based on scoring: 0–2 indicates low risk of OSA; 3–4 indicates
intermediate risk; 5–8 indicates high risk66. We will follow these
guidelines for classifying patients as HR-OSA, IR-OSA, or
LR-OSA for our primary analysis, and thus likely demonstrate
important trends between and among groups.
Of note, current literature classifies, often for simplicity, a
STOP-Bang score of ≥3 as high risk for OSA. However, this can

obscure analysis, potentially resulting in a falsely weaker association between OSA risk and risk of postoperative adverse
outcomes. Therefore, we will not group intermediate risk of
OSA with high risk of OSA. Also, some literature incorporates
bicarbonate levels to help determine OSA risk. As baseline
laboratory values are not available for each participant, we
will not include this component for classifying OSA risk.
For secondary analysis (Figure 2), we will analyze delirium
incidence and pain severity among five patient groupings:
confirmed OSA + report using prescribed CPAP, confirmed
OSA + report not using prescribed CPAP, high risk for OSA
(STOP-Bang 5–8), intermediate risk for OSA (STOP-Bang 3–4),
low risk for OSA (STOP-Bang <3). Thus, secondary analysis will
likely demonstrate if reported CPAP adherence mitigates these
adverse outcomes.
v. Sample Size. We estimate that we will have data with complete
outcomes (pain severity and incident delirium) and information on
OSA status for approximately 1,500 patients. We estimate that 300
(~20%) of these patients will have incident postoperative delirium.
We will have patient reported pain outcomes for all participants.
We will use logistic and linear regression, including potential confounder variables, to test for an independent association between
OSA as a risk factor and postoperative delirium and pain severity
as outcomes of interest. We estimate that it will be appropriate to
include up to 25 variables in each of the regression models.

Figure 1. Predicted groupings for OSA-risk classification in the primary analysis, based on previous data from our preoperative
assessment clinic7.
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Figure 2. Predicted groupings for OSA-risk classification in the secondary analysis, based on previous data from our preoperative
assessment clinic7.

Data management
All electronic data collected during this study, as well as the
SATISFY-SOS, ENGAGES, and PODCAST databases, are hosted
on a firewall-secured network server. This server is managed
and maintained by the IT team of the Department of Anesthesiology, and is securely housed behind two locked doors in the
departmental offices. The Project Informaticist, Data Manager,
and Director(s) are the only individuals with full access to these
password-protected and encrypted databases. Delirium and pain
assessments are first completed using paper surveys, which are then
securely stored in locked cabinets within the department. Results
are entered into a Research Electronic Data Capture (REDCap) tool
hosted at Washington University School of Medicine in St. Louis67.
REDCap is a secure, web-based application designed to support
data capture for research studies, providing: 1) an intuitive interface
for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures
for seamless data downloads to common statistical packages;
and 4) procedures for importing data from external sources.
i. Statistical considerations. Continuous variables will be
graphically evaluated with histograms, boxplots, and q-q plots,
and numerically with measures of skewness, kurtosis, and
Kolmogorov-Smirnov tests. Outliers will be excluded, and approximate normality will be ensured before parametric statistics are
applied. Perioperative variables will be described with mean ±
SD, median [IQR], and numbers/proportions, as appropriate.

Differences in patient and other perioperative factors between
groups will be evaluated with chi-squared, t-tests, ANOVA,
Kruskal-Wallis, and/or Wilcoxon-Mann-Whitney tests, as
appropriate. Multiple imputation methods will be used for
patients’ missing variables, but participants with missing
outcomes will be excluded from analysis.
ii. Delirium. Logistic Regression will be used to assess the
relationship between OSA as a risk factor and incident
postoperative delirium as an outcome. For our analyses, we will
include no more than 1 variable for every 10 outcomes. With an
estimated incident postoperative delirium rate of 20%, we plan
to include up to 25 pre-specified candidate predictor variables
in the primary regression models, including the most clinically
relevant interaction terms. Variables for our primary analysis have
been selected based on existing evidence, and will likely include:
OSA status; Age; Sex; Type of Surgery; Charlson Comorbidity
Index; Procedural Cardiac Risk; ASA physical status; Alcohol
use; preoperative midazolam use; median volatile anesthetic
concentration (converted to minimum alveolar concentration
[MAC] equivalents); intraoperative ketamine use; intraoperative
opioids (converted to morphine equivalents in mg); and anesthesia
time in minutes. We will also include a history of any of the
following comorbidities: COPD or Asthma; Stroke; Dementia
or Mild Cognitive Impairment; Visual or hearing Impairment;
Depression or Anxiety; Chronic Pain; and Diabetes Mellitus.
We hope to include BMI and age independently of the OSA risk
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classification since they are continuous variables, and their
inclusion in the regressions might improve the models. We
also hope to include the variable ‘tiredness’ in the models since
this particular symptom could plausibly independently predict
both delirium and pain. However, there may be statistical
limitations (i.e. collinearity) preventing inclusion of some of these
variables. If so, we may exclude some variables and describe our
adjustments in the manuscript.
iii. Pain. Linear Regression will be used to examine OSA’s
potential relationship to postoperative pain. For this analysis,
the outcome is continuous rather than binary, and will apply to
all 1,500 patients. It will be reasonable to include up to 25 prespecified candidate predictor variables in the linear regression
models, including interaction terms. As risk factors for delirium
and pain are overlapping, the same candidate predictor variables
will be used in this regression. Sensitivity analyses will be
conducted to address limitations regarding pain. Since it is
important to consider delirious patients might be unable to report
pain accurately, we plan to conduct a sensitivity analysis with pain
as the outcome, excluding all the patients who were diagnosed
with postoperative delirium. We also hope to explore any potential
relationship between OSA risk and total postoperative opioids
given during hospital stay (expressed as morphine equivalents in
mg). Additionally, since our primary analysis will not consider
duration of severe pain or distinguish between rest and provoked
pain, we plan to conduct a sensitivity analysis with median
provoked pain during hospital stay (up to postoperative day 3)
as the outcome. The responses to two VAS questions (pain when
(i) taking a deep breath or coughing, and (ii) moving (sitting up,
walking, or moving extremities)) will be compiled to represent
provoked pain during hospital stay.

Anticipated results
We expect that patients with a high risk of OSA will experience
greater postoperative pain severity, and have a higher risk for
postoperative delirium following surgical procedures. For our
secondary analyses, we propose that these adverse outcomes
might be modified by compliance with CPAP treatment. We
predict patients with diagnosed OSA who do not use prescribed CPAP will experience a higher incidence of delirium and
increased pain. We also expect a step-wise increase in these
adverse outcomes (delirium incidence and pain severity) when
analyzing patients based on their STOP-Bang assessment groups
(high risk vs. intermediate risk vs. low risk).

Discussion
OSA is a common and frequently undiagnosed perioperative
problem. This observational study will help to clarify whether or
not OSA is an independent predictor of postoperative incident
delirium and acute postoperative pain. Secondary analyses
may show if these adverse outcomes might be modified by
compliance with OSA treatment.
In this study, we will attempt to replicate the reported finding
showing that OSA is an independent predictor of postoperative
delirium and acute postsurgical pain severity32–34. This study will
have important strengths compared to the existing literature;

most notably the database including routine structured preoperative screening for OSA, and postoperative delirium and pain
assessments on a broad surgical population. The researchers who
collected data for this study were all expertly trained in administering delirium and pain assessments. In an effort to improve methodological rigor, we have pre-specified independent variables for
regression models, and have described our statistical analyses.
This study will also have important limitations. Although we
will have thorough medical histories routinely collected from
preoperative clinic assessments, we will not know severity of OSA
or other comorbidities. In common with any observational study,
this study will be unable to distinguish association from causation. In particular, if we do find in this study that OSA is associated with either increased delirium incidence or pain severity, we
will not be able to determine (i) whether OSA is causally implicated or (ii) whether there is another explanatory factor associated
with both OSA and these outcomes. Regarding the outcome of
delirium, this study will address on the crude association with
incident delirium as a binary outcome. It might be more important
to focus on either the duration or severity of delirium. Regarding pain, it is important to consider that delirious patients might
be unable to report pain accurately. This limitation is common to
all studies evaluating postoperative pain. To mitigate this to an
extent, we plan to conduct a sensitivity analysis with highest VAS
pain score as the outcome, excluding all the patients who were
diagnosed with postoperative delirium. Also in relation to
pain, our primary outcome will be most severe pain reported in
postoperative days 1–3. This approach will not consider duration
of severe pain or distinguish between rest and provoked pain. To
mitigate this to an extent, we plan to conduct a sensitivity analysis
exploring median provoked pain through postoperative day 3 as
the outcome. Additionally, it will be important to include analgesic medication as potential confounders in the regression analyses,
and accurate data on these might not be available.
In conclusion, while likely providing stronger evidence regarding
the impact of OSA on postoperative delirium and pain, this study
might also discern interventional strategies for treatment and
prevention. For example, in relation to delirium, we could test
perioperative delirium prevention bundles in patients with OSA
or we could investigate whether preoperative initiation of CPAP
treatment decreases this complication. The role of CPAP therapy
in relation to improved analgesia should also be clarified.
Regarding pain, we could further develop analgesic plans
especially for surgical patients with OSA, such as emphasizing
regional analgesia or non-opioid analgesics. We could also
implement procedures intended to improve the safety of patients
with OSA receiving respiratory depressant medications in the
perioperative period. With emerging knowledge about biased
signaling with opioids68, it is possible that certain opioids
(e.g. morphine) are safer than others (e.g., Fentanyl) for patients
with OSA in terms of their propensity to provide analgesia
rather than to cause respiratory depression. We hope to use
the foundational work proposed in this observational study to
guide the design of such trials and clinical plans, with the
goals of reducing postoperative delirium and acute postoperative
pain severity for the large number of patients at risk due to OSA.
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by the Department of Anesthesiology, which is securely stored
behind two locked doors within the departmental office suite. Only
Health Insurance Portability Accountability Act (HIPPA)-trained
employees of the Department of Anesthesia or Barnes Jewish
Healthcare have access to resources on the private network server.
The three parent studies from which the data are being obtained
for the current study have all been approved by the Human
Research Protection Office (HRPO) at Washington University, and
patients enrolled in all three studies provided written informed
consent. The HRPO has also provided approval for this current
study.
Registration, Reporting, and dissemination
The three parent studies from which data for this study are being
used have all been registered at clinicaltrials.gov. SATISFY-SOS
is registered as NCT02032030. ENGAGES is registered as
NCT02241655. PODCAST is registered as NCT01690988j.
Results of this study will be presented at national meetings and
published in a scientific journal. Participants will not be
individually notified regarding the results of this study.
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Thank you for submitting this interesting study protocol aiming to investigate the relationship between
OSA and postoperative delirium as well as pain severity. This protocol targets an important and clinically
meaningful research question, and is overall well written and designed. We invite the authors to
consider the following questions and suggestions:
1. Please address the question as to whether the patients are studied from a historical cohort. If so,
how do you control for the effects of previously studied interventions (e.g. effect of anesthetic
protocols on postoperative delirium in the ENGAGES study; effects of ketamine treatment on
postoperative delirium and pain (PODCAST study)) ?

2. How do you discriminate between lingering medication effects and delirium early on during
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2. How do you discriminate between lingering medication effects and delirium early on during
postoperative day 1?
3. We suggest considering to additionally use the SPOSA score which was recently published in
order to classify patients according to OSA risk (Shin C et al. BMC Anesthesiology 2017).
Advantage is you can apply this to bigger observational cohorts without measuring neck
circumference etc.
4. Maybe you can better justify the patient flow. The SATISFY-SOS study aims to enroll 36000
patients. Please provide information that helps understand as to why you expect to have complete
data for ~1300 patients only. Looks like you also want to use data from two other studies
additionally with enrollment targets of additional 600 and 1200 patients?
5. How do you account for patients with undiagnosed OSA that may have been treated with CPAP for
other respiratory diseases such as COPD, acute lung injury, neuromuscular disorders etc.?
6. Statistical models:
1. Confounder control: Please consider including comorbidities such as COPD, asthma and
neuromuscular disorders in the context of higher risk for intraoperative hypoxemia or
respiratory failure; duration of surgery/time under anesthesia in addition to surgery type and
some type of measure for procedural complexity such as a risk quantification score (see
PSS for Morbidity or Mortality) into your statistical model
2. For sure you should control for age and BMI
3. Consider including pre-prescribed drugs especially neuroleptics/antipsychotics if you can
get these data
4. Perhaps also consider accounting for different anesthetic protocols used during surgery
such as TIVAs, volatile anesthetics, opioid use, ketamine use
5. Did you consider using multiple imputation methods for missing data?
6. We like the suggested sensitivity analyses.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
Competing Interests: No competing interests were disclosed.
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard, however we have significant reservations,
as outlined above.

Author Response 04 Jun 2018
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Author Response 04 Jun 2018

Patricia Strutz, Washington University in St. Louis School of Medicine, USA
Thank you, Dr. Eikermann and Dr. Timm, for your feedback on our study protocol. We sincerely
appreciate your time and thoughtful suggestions. Along with submitting our revised protocol, we
directly address your suggestions and questions below.
1. Please address the question as to whether the patients are studied from a historical cohort.
If so, how do you control for the effects of previously studied interventions (e.g. effect of
anesthetic protocols on postoperative delirium in the ENGAGES study; effects of ketamine
treatment on postoperative delirium and pain (PODCAST study)) ?
We have included more details about our cohort under the “Study Design” section. Briefly, yes the
patients are studied from a historical cohort, and we have improved our model to adjust for
randomization group from the previously studied interventions. Although the PODCAST trial did
not have significant findings, we agree that controlling for group allocation provides a more robust
analysis.
1. How do you discriminate between lingering medication effects and delirium early on during
postoperative day 1?
We have added details regarding our delirium assessments under “Data collection: Delirium
assessment method.” All POD 1 assessments were administered in the afternoon between 1pm
and 8pm. Patients were assessed on POD 0; however we are excluding these assessments
because of potential lingering general anesthetic effects. We are also now adjusting our model for
the use of certain medications, such as preoperative midazolam, median volatile anesthetic
concentration (converted to minimum alveolar concentration [MAC] equivalents), intraoperative
ketamine, and intraoperative opioids (converted to morphine equivalents in mg).
1. We suggest considering to additionally use the SPOSA score which was recently published
in order to classify patients according to OSA risk (Shin C et al. BMC Anesthesiology 2017).
Advantage is you can apply this to bigger observational cohorts without measuring neck
circumference etc.
Thank you for this suggestion! We are unable to incorporate the SPOSA score for this cohort
because of limiting factors with electronic medical data. However, we are excited about this new
model and the ability to classify OSA risk in larger cohorts, especially when neck circumference is
unavailable.
1. Maybe you can better justify the patient flow. The SATISFY-SOS study aims to enroll 36000
patients. Please provide information that helps understand as to why you expect to have
complete data for ~1300 patients only. Looks like you also want to use data from two other
studies additionally with enrollment targets of additional 600 and 1200 patients?
We have included more details about patient flow under the “Study Design” section. We now hope
to include all 1200 patients from the ENGAGES trial. Of the ~600 patients in the PODCAST study,
we will include those patients recruited through Washington University in St. Louis (roughly 100
patients). Although SATISFY-SOS aims to enroll a large number of patients, only 200 of those
patients received daily inpatient delirium and pain assessments.
1. How do you account for patients with undiagnosed OSA that may have been treated with
CPAP for other respiratory diseases such as COPD, acute lung injury, neuromuscular
disorders etc.?
The data to classify patient reported CPAP use comes from routine questions that are part of our
OSA screening done in our pre-operative clinic. Specifically, we ask patients who have been
diagnosed with OSA if they are prescribed CPAP (or an alternative OSA PAP treatment) and if they
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diagnosed with OSA if they are prescribed CPAP (or an alternative OSA PAP treatment) and if they
use their CPAP. Unfortunately in this study, we are unable to account for patients with undiagnosed
OSA who may have been treated with CPAP for other respiratory diseases. This has the potential
to decrease any difference in outcomes we may see between the study groups and bias our
findings towards the null hypothesis (H0= no difference in outcomes between the groups). This
would be a limitation of our secondary sub-group analysis, which we would discuss in our
manuscript.
1. Statistical models:
1. Confounder control: Please consider including comorbidities such as COPD, asthma
and neuromuscular disorders in the context of higher risk for intraoperative
hypoxemia or respiratory failure; duration of surgery/time under anesthesia in
addition to surgery type and some type of measure for procedural complexity such as
a risk quantification score (see PSS for Morbidity or Mortality) into your statistical
model
2. For sure you should control for age and BMI
3. Consider including pre-prescribed drugs especially neuroleptics/antipsychotics if you
can get these data
4. Perhaps also consider accounting for different anesthetic protocols used during
surgery such as TIVAs, volatile anesthetics, opioid use, ketamine use
5. Did you consider using multiple imputation methods for missing data?
6. We like the suggested sensitivity analyses.
Thank you for these suggestions- they have helped us improve our statistical models. We will
include COPD, asthma, and anesthesia time in minutes; however we will not be able to include
history of neuromuscular disorders or pre-prescribed drugs. Additionally, we will adjust our models
for medications used during surgery. We are still hopeful to include age and BMI, but collinearity
may prevent us from incorporating these variables independently. We will explain any statistical
limitations in the manuscript. Again, thank you for your time and your suggestions!
Competing Interests: none

Referee Report 29 March 2018

doi:10.5256/f1000research.15295.r32028
Jean Wong 1, Frances Chung 2
1 Department of Anesthesia, University of Toronto, Toronto, ON, Canada
2 University Health Network, University of Toronto, Department of Anesthesia, Toronto Western Hospital,

Toronto, ON, Canada
This study proposes to retrospectively examine data previously collected from 3 prospective studies to
test whether OSA is an independent predictor of postoperative delirium and acute postoperative pain
severity.
The study is described as ‘observational’ however, the study examines data that was already collected,
and so I believe the title should be adjusted to reflect this a retrospective study.
The incidence of delirium varies depending on the type of surgery and is lower than 20% for some
elective surgeries. The type of surgery included should be mentioned.
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The incidence of delirium varies depending on the type of surgery and is lower than 20% for some
elective surgeries. The type of surgery included should be mentioned.
Whether the patients may have a history of chronic pain should be included. As well, although the patients
had a history of using CPAP, ideally, whether the patients were compliant with the use of CPAP while in
hospital and the number of hours of CPAP use should be reported.
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Not applicable
Competing Interests: No competing interests were disclosed.
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard.
Author Response 04 Jun 2018

Patricia Strutz, Washington University in St. Louis School of Medicine, USA
Thank you, Dr. Wong and Dr. Chung, for your feedback on our study protocol. We sincerely
appreciate your time and thoughtful suggestions. Along with submitting our revised protocol, we
would like to directly address some suggestions. We will be including type of surgery as an
independent variable in our regression models, and we will also be adjusting our analysis for a
history of chronic pain. We agree with your suggestion to report hospital CPAP use.
Unfortunately, we do not have that information available to us and are unable to provide a more
robust measure of CPAP adherence- a limitation we would discuss in our manuscript. Again, thank
you for your time.
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